中国医药生物技术
中國醫藥生物技術
중국의약생물기술
Chinese Medicinal Biotechnology
2015年
5期
411-415
,共5页
武燕彬%金洁%王瑞贞%刘浚%王翀%陈晓芳
武燕彬%金潔%王瑞貞%劉浚%王翀%陳曉芳
무연빈%금길%왕서정%류준%왕충%진효방
HIV 整合酶抑制剂%构效关系%双二酮酸类化合物
HIV 整閤酶抑製劑%構效關繫%雙二酮痠類化閤物
HIV 정합매억제제%구효관계%쌍이동산류화합물
HIV integrase inhibitors%Structure-activity relationship%Bis-diketo acid compound
目的设计合成双二酮酸类化合物,并探讨此类化合物抑制 HIV-1整合酶活性的构效关系。<br> 方法以甲基取代苯乙酮为起始原料,经溴代后与羟基取代苯乙酮反应生成乙酰基苄氧苯乙酮,然后在氢化钠作用下,脱去α氢后进攻草酸二乙酯生成双二酮酸酯,水解脱去酯基生成双二酮酸;经1H-NMR、IR和 MS验证化合物结构。ELISA法测定目标化合物对 HIV-1整合酶的抑制活性;采用高通量荧光法测定目标化合物对 HIV-1整合酶3'加工过程的抑制活性;测定目标化合物对 HIV假病毒的细胞活性。<br> 结果合成了6个全新结构的二酮酸类化合物;体外整合酶活性评价结果表明,6个目标化合物对 HIV-1整合酶的活性 IC50≤20μg/ml,双二酮酸之间距离稍短的5a、5c、5d对3'加工过程有一定的活性,IC50约为40μg/ml。<br> 结论6个新化合物对 HIV-1的活性主要表现在链转移过程。
目的設計閤成雙二酮痠類化閤物,併探討此類化閤物抑製 HIV-1整閤酶活性的構效關繫。<br> 方法以甲基取代苯乙酮為起始原料,經溴代後與羥基取代苯乙酮反應生成乙酰基芐氧苯乙酮,然後在氫化鈉作用下,脫去α氫後進攻草痠二乙酯生成雙二酮痠酯,水解脫去酯基生成雙二酮痠;經1H-NMR、IR和 MS驗證化閤物結構。ELISA法測定目標化閤物對 HIV-1整閤酶的抑製活性;採用高通量熒光法測定目標化閤物對 HIV-1整閤酶3'加工過程的抑製活性;測定目標化閤物對 HIV假病毒的細胞活性。<br> 結果閤成瞭6箇全新結構的二酮痠類化閤物;體外整閤酶活性評價結果錶明,6箇目標化閤物對 HIV-1整閤酶的活性 IC50≤20μg/ml,雙二酮痠之間距離稍短的5a、5c、5d對3'加工過程有一定的活性,IC50約為40μg/ml。<br> 結論6箇新化閤物對 HIV-1的活性主要錶現在鏈轉移過程。
목적설계합성쌍이동산류화합물,병탐토차류화합물억제 HIV-1정합매활성적구효관계。<br> 방법이갑기취대분을동위기시원료,경추대후여간기취대분을동반응생성을선기변양분을동,연후재경화납작용하,탈거α경후진공초산이을지생성쌍이동산지,수해탈거지기생성쌍이동산;경1H-NMR、IR화 MS험증화합물결구。ELISA법측정목표화합물대 HIV-1정합매적억제활성;채용고통량형광법측정목표화합물대 HIV-1정합매3'가공과정적억제활성;측정목표화합물대 HIV가병독적세포활성。<br> 결과합성료6개전신결구적이동산류화합물;체외정합매활성평개결과표명,6개목표화합물대 HIV-1정합매적활성 IC50≤20μg/ml,쌍이동산지간거리초단적5a、5c、5d대3'가공과정유일정적활성,IC50약위40μg/ml。<br> 결론6개신화합물대 HIV-1적활성주요표현재련전이과정。
Objective To explore the relationship of structure and activity of these compounds with anti HIV-1 integrase through designing and synthesizing a series of novel bis-diketo acid compounds. <br> Methods Title compounds were synthesized through bromination, substitution and hydrolyzation. 6 target compounds were obtained. All structures were confirmed by1H-NMR, IR and MS. Anti HIV-1 integrase activitiesin vitro of the target compounds were tested by ELISA, high-throughput fluorescence method was used to anti HIV-1 integrase 3P activities, and HIV-1 pseudovirus was applied to determine the infection rate of cells inhibited by the compounds. <br> Results 6 novel compounds were synthesized. The title compounds exhibited moderate anti-integrase activity with IC50≤ 20μg/ml. Three target compounds exhibited 3P activity with IC50≈ 40μg/ml. <br> Conclusion 6 novel compounds exihibit mainly ST activity. The study will help to understand the relationship of structure and activity of compounds with anti HIV-1 activities.